DOCSLIB.ORG

H.Hller*, K.Miller*, B.Cwcke*, A.Attar?Dsio,D.Qpta. Culture

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
H.Hller*, K.Miller*, B.Cwcke*, A.Attar?Dsio,D.Qpta. Culture E.FrCjavilleX, H.C. Pifferi*, C.Cesarif, S.Partesottix. G.Pagnix.C. N.G.Forest, A.Ltcoqx and PI.David*. IIJSER1:-U. j'l Pediatric Clinic, HGpital Debrousse, Lyon, France. Tramonti*, V.Santi*, L.AbatiX, E.Cacciari 128 25 SEX HCRMONE BIIIDII<G PROTEIN (C6P) AS A MARKEh Of' Lnd Pediatric Clinic and 2nd Obstetric Clinic, University of Bolo- ANDROGEN SENSITIVITY IN INFANTS AND CHILDREN. gna, Italy. BREAST CONTACT THERNOGRAPHY IN DIFFERENTIAL DIAGNOSIS OF PREMATURE Establishing a reliable test of androgen SfnSlti- THELARCHE AND PRECOCIOUS PUBERTY. vity is still prerequisite for etiological disgnosis in order to contribute to the differential diagnosis between idiopathic in infants suspected of androgen insensitivity syndr20me (.&IS). Premature Thelarche (PT)and true Precocious Puberty (PP) ue performed Breast Since androgens are known to decrehse SBP levels we have invcsti- Contact Thermoaraohv (BCT. cholesteric liouid crystal ~lates)in 13 airls vith PI gated the possibility of using plaslna SBP as a marker of andro~ell A,,. and 12 vith PP (previously diagnosed) and in105 controlgirls (~~~~~~t~ 81.5). ~Cn~itivity,and studied the conditions for a ratlonal protocol. The Ontokenic Of birth was first We evaluated the 4 principal components (Fundus, vascularization, nipple and established in 695 controls, (by a solid phase method). SEP periareolar heat changes). Arbitrary gradual scores (0,I.Z ...) uere attributed to (Ug/l) low at birth, (~-3~3)rise to 22.3t7.5 during the the maturative signs. A Thermographic Index (TI= sum of the 4 scores of a single first montti of life correlatively with time, with no sex diffcren- breast) and the higher TI (hTI= betueen the 2 breasts of single girls) were ce but larbe individual variations. In aodition, SBP decreased calculated..-~~-~- significantly after either an acute or a ?-day routine ACTH test. Whatever the age (1 mo-13 yr), SBP levels decreased significbntly Results: in controls, single scores, TI and hTI had a positive correlation - (c, (mean=30%) in a group of 40 boys at the end (day 14) of an hCG p <0.001) with B stages. In PI, all signs of vasculariration Mere aluays (100%) test (1500 IU/48 h x 7), but the responsf was very varidble arid absent, while in PP they uere aluays present, although in some cases monolateral- not with testosterone levels. sn cony.ast, the exo- ly. The TI of PI uas not different from 01 girls and significantly louer genous administration of fluoxyrnesterone (10 mg/q /d.x 10 (1.) or (p<0.001) than PP girls and B>1 controls. The hTI ranged from 0 to 3 in PT, from depo-testosterone (4 IM injections of 100 mg/mL every 2 ,decks) 4 to 13 in PP airls. induced a siginificant drop (mean 2 fold) in 10 infants witt, idio- We conclude that lou TI (< 3)and no signs of vascularizationindicate PI, pathic male pseudOhermaphroditism, but not in 2 susl;ected of AIC. In ConclusiOn' SBP appears 'Ood 'larker Of androgen sensitivity vascular hyperthermia and hTI2 4 indicate PP. We emphasize the useful diagnostic in infancy, however establishing a protocol requires thrce aid of the noninvasive imaging technique of BCT in evaluating the pathophysiology conditions: 1) the test should not be done ourlnc the lst month -~ ~-~-~-. of pubertal breast development. of life (rising basal levels), 2) neither after an ACTli test and 3) utilise the exogenous administration of a high dose of androgens for somewhat a prolonged period of time. L.AU~I*,A. Carrascosa*, D.Yeste* , A. Ballabriga* H.hller*, K.Miller*, B.Cwcke*, A.Attar?dsio,D.Qpta. ( Introd. bv C. Marti-Henneberq ) 129 Lkpt-Diagwstic EnQcriwlcgy,lhiv.Childrtrl's tbspital, Aospital Germans Trias-Pujol & Hospital Infant11 de 74 ~bii@n, FRG. la Val1 d'Hebron,Autonomous University of Barcelona AGE-DEPWNT EFFECTS OF MLATONIN PCMINISTR4TICN CN PROSTATIC S~ain. CYTOSOL AUCGN ECEPTOR5 IN M4LE RATS SPECIFIC ANDROGEN BINDING IN HUMAN FETAL EPIPHYSEAL CHONDRCCYTES IN CULTURE . Human fetal epiphyseal chondrocytes were obtained in primary Chronic daily adninistration of relatonin (MT) can have pterh effects on culture ( Ped. Res. 19:720,1985 ) . In this system testosterone rqm.3xtiffl in the experimtal animals. Various theories have been elaborated (T) was metabolized into androstendione and dihydrotestosterone to explain these "piml" effects on gonads. In the preserh study we have (DHT) ( J. Clin. Endocrinol. Metab. 58:819,1984 ) and we have re- exanired the prostatic cytosol ardrcpn receptor (AR) respnse in pubertal cently shown that DHT significantly stimulates chondrocyte proli- (35-day-old) and adult (70-day-old) mle Wistar rats to doses of 250 &kg b.w. feration . MT (in 0.5 ml saline) adninistered s.c. for 4 days at 17.00 hr each day with In order to study the mechanism of androgen action on human fe 12 h (6.m18.00 h) light per day. The control group received only saline tal epiphyseal cho drocytes , cells have been incubated with DHT- for 4 consecutive days. The animls were sacrificed at 7 a.m. follcwiq the 3H ( 0.1 - 9 x 10-gM ) with and without 200-fold unlabelled DHT last dose. In the pubertal group 6 pls wt of 24 animls the rean cytosol for 30.at 37% . Cells were sonicated in Tris 0.02M-HCl pH=7.5 , PSI declined significantly (p-0.03) fma level of 263120 fnoll~W4 sea 0.5 M KC1 , 1.5 mM EDTA , 2 mM Mercaptoethanol . Unbound DHT was in the control animals to a level of 94.3+119 fml11rg for the MT-treated separated with KCBuffer . Maximal binding capacity and Kd were group. There was also a decline for the c@sol receptors in the adult group calculated according to a Scatchard plot . In chondrocytes from bch the difference did not reach significance. Interestiqly, the studies fetuses ( 20-40 weeks-old ; 4 #and 4 O ) Bmax In fis 4.2 ; 1.2 again ccnfinred that pernaps cytosol AR is wt dependerrt on tesbsterow, fmol/mg Prot. and in 0 5.5 ;0.5 ; Kd 1s 0.34 ;0.14 nM in dand as there was w difference in testostem levels bet- the control and the 0.65 ;0.21 in 9 . ~o+differencewas found for sex nor for gesta- experirmtal gmps. Chronic injections of MT for 4 days in adult bch rat tional age . in ymanimls suppressed circulatitq MT levels Wen sarples were collected Human fetal epiphyseal chondrocytes in primary culture seem 14 h after last irljectim. The current study convinciqly dglanstrates that therefore to present proteins which may act as typlcal specific chmic injections of MT for 4 days in the late light phase of the light- androgen receptors . These results suggest that biological acti- dark cycle have marked inhibitory effeds on the prostatic cytosol AR in the vity of androgens on human fetal epiphyseal chondrocytes in cul- pubertal animls bch wt in the adults as was evidenced earlier in an in- ture may be mediated through specific receptors . direct exprimnt (bller et al. (I=), Res Exp M 183,157-165). I.A. HUGHES, B.A.J. EVANS? Department of Child 130 M.Muritano*, M.Zachmann, A.Prader 127 Health, University of Wales College of Medicine, Department of Pediatrics, University of Zurich, Cardiff. OK- Switzerland. TRANSIENT OVARIAN TESTOSTERONE AND ANDROSTENEDIONE ANDROGEN INSENSITIVITY (A11 IN 43 PATIENTS: HYPERSECRETION: A CAUSE OF VIRILISATION OR PREMATURE CLASSIFICATION BASED ON CLINICAL AND ANDROGEN PUBARCHE IN PREPUBERTAL GIRLS RECEPTORS CAR) PHENOTYPES. Androgen binding was studied in genital skin fibroblasts (GSF) In two unrelated girls with signs of excessive androgen pro- established from XY patients with testes displaying signs of duction ,the usual causes (premature adrenarche, mild congenital complete androgen insensitivity syndrome (CAIS, n = 14) and partial adrenal hyperplasia, adrenal or ovarian tumor) were excluded. Pa- AIS (n = 29). Total whole-cell AR concentrati.on (Bmax) in GSF tient 1 presented at age 3.6 (bone age (BA) 3.75) yrs with hyper- strains derived from 31 normal circumcised boys was 775 * 185 x trophy (3cm) of the clitoris and erections. Urinary total 17KS 10-% mollpg DNA (mean f SD). The AR phenotype was receptor- (0.7mgId) and individual steroids (5-pregnenetrio1,pregnanetriol- negative in 79% of CAIS patients; however, the remaining 21% in one,THS,THDOC,individual 17KS) and plasma DHEA(4.8) and 170HP(2.7 this series had su ranormal AR concentrations (mean 1840, range nmolll) Were n0rmal.Plasma estradiol (E2,142pmol/l) Was minimally 1541 - 2072 x 10-1f mollpg DNA). Further studies on these cell elevated,but testosterone (T,8.2) and androstenedione (A,10.4nmol strains showed stable androgen binding at 4PC, normal 11) were high. At laparotomy, ovarian cysts without evidence of a dissociation rate for the AR complex, appropriate GSF cytosol tumor were found and removed. After surgery, T(0.7) and A(1.6nmol sedimentation on sucrose density gradients in the presence of /l )returned to normal and remained so during 5yrs of observation. molybdate and 60% binding of the androgen Ligand located in the The clitoris did not change, but erections occurred no longer. nuclei. Only 7% of GSF strains from patients with PAIS were Patient 2 presented at 7.8 (BA 9.1) yrs with pubic (stage 2) and AR-negative; mean * SD concentration of AR in the remainder was axillary hair. Urinary 17KS(1.9 mgld) and individual steroids, as 837 f 315 x 10-18 mollpg DNA. No PAIS cell strain contained well as plasma DHEA(7.7),170HP(3.3nmol/l),and E2(139pmol/l) were a supranormal AR concentration. More than 90% of AR-positive normal, but T (7.7) and A (8.1 nmolll) were elevated. Echography cell strains (including those with supranormal AR Levels) showed polycystic ovaries.
Load more

Recommended publications
  • Treatment of Peripheral Precocious Puberty
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by IUPUIScholarWorks Treatment of Peripheral Precocious Puberty Melissa Schoelwer, MD and Erica A Eugster, MD Section of Pediatric Endocrinology, Department of Pediatrics, Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, Indiana Send correspondence to: 705 Riley Hospital Drive, Room 5960 Indianapolis, IN 46202 Phone: 317-944-3889 Fax: 317-944-3882 Email: [email protected] __________________________________________________________________________________________ This is the author's manuscript of the article published in final edited form as: Schoelwer, M., & Eugster, E. A. (2016). Treatment of Peripheral Precocious Puberty. In Puberty from Bench to Clinic (Vol. 29, pp. 230-239). Karger Publishers. http://dx.doi.org/10.1159/000438895 Peripheral Precocious Puberty Abstract There are many etiologies of peripheral precocious puberty (PPP) with diverse manifestations resulting from exposure to androgens, estrogens, or both. The clinical presentation depends on the underlying process and may be acute or gradual. The primary goals of therapy are to halt pubertal development and restore sex steroids to prepubertal values. Attenuation of linear growth velocity and rate of skeletal maturation in order to maximize height potential are additional considerations for many patients. McCune-Albright syndrome (MAS) and Familial Male-Limited Precocious Puberty (FMPP) represent rare causes of PPP that arise from activating mutations in GNAS1 and the LH receptor gene, respectively. Several different therapeutic approaches have been investigated for both conditions with variable success. Experience to date suggests that the ideal therapy for precocious puberty secondary to MAS in girls remains elusive. In contrast, while the number of treated patients remains small, several successful therapeutic options for FMPP are available.
    [Show full text]
  • Precocious Puberty Children with Spina BiDa and Hydrocephalus May Start Puberty Earlier Than Their Peers
    SBA National Resource Center: 800-621-3141 Precocious Puberty Children with Spina Bida and hydrocephalus may start puberty earlier than their peers. What is Puberty? If major breast development starts before age 8, it is considered early. (Sometimes girls will have some Puberty refers to normal body changes that lead to breast development, with no other signs of puberty. maturity and the ability to have children. Normal puberty This isolated change may be normal.) begins between ages 8 and 12 in girls and between 9 and 14 in boys. Hormones made in the brain control the timing and sequence of puberty. These hormones What are the stages of normal puberty in boys? stimulate other parts of the body to make sex hormones. The usual sequence in boys is: The sex hormones, especially estrogen in girls and testosterone in boys, cause sexual maturation. • The testicles grow larger. • The penis grows larger. What are the stages of normal puberty in girls? • Pubic hair grows. The physical changes seen in puberty are labeled by “Tanner staging.” Stage 1 is child-like (before puberty) • There is a growth spurt.rt. and stage 5 is full maturity. The usual sequence in girls is: • Other body hair grows.s. • Breasts start to develop. If boys show major developmentelopment • Hips widen and a there is a growth spurt that usually before age 9, it is considereddered lasts about three to four years. early. Early puberty in girls or boys is called • Pubic hair grows (three-to-six months after breasts “Precocious Puberty.” develop). • Other body hair grows.
    [Show full text]
  • Precocious Puberty: a Red Flag for Malignancy in Childhood
    CLINICAL Paul R. D’Alessandro, MD, MSc, Jillian Hamilton, MBChB, Karine Khatchadourian, MD, MSc, Ewa Lunaczek-Motyka, MD, Kirk R. Schultz, MD, Daniel Metzger, MD, Rebecca J. Deyell, MD, MHSc Precocious puberty: A red flag for malignancy in childhood Three clinical cases of precocious puberty resulting from rare but serious functional solid tumors in children highlight the need for physicians to identify the condition early and refer to tertiary care to minimize morbidity and optimize survival. ABSTRACT: Pediatric solid tumors have a range of 1-3 Dr D’Alessandro is a pediatric hematology/ abnormalities. These tumors may present clinical presentations, including those driven by oncology subspecialty resident in the with early onset of isosexual or contrasexual the ectopic production of hormones secreted by Division of Pediatric Hematology, Oncology, puberty as a first symptom. Treatment may some malignancies. Functional tumors lead to a and Bone Marrow Transplant, Department involve surgery, chemotherapy, and/or radio- variety of presentations, including Cushing syn- of Pediatrics, University of British therapy. Genetic testing or counseling may be drome, growth acceleration, abnormal virilization Columbia, British Columbia Children’s indicated for families. Early identification mini- or feminization, and hypertension with electrolyte Hospital Research Institute. mizes disease-related morbidity and mortality abnormalities. Precocious puberty, the onset of Dr Hamilton is a general practice specialty and optimizes outcomes. We present illustrative secondary sexual characteristics before age 8 in trainee, NHS Forth Valley, Larbert, cases of functional solid tumors in children from girls or 9 in boys, may be a warning sign of occult United Kingdom. Dr Khatchadourian is a British Columbia with the aim of educating malignancy.
    [Show full text]
  • Precocious Puberty
    Precocious Puberty The Pituitary Gland: The "Master Gland" The pituitary gland, which is often referred to as the "master gland", regulates the release of most of the body's hormones (chemical messengers that send information to different parts of the body). It is a pea-sized gland that is located underneath the brain. The pituitary gland controls the release of thyroid, adrenal, growth and sex hormones. The hypothalamus, located in the brain above the pituitary gland, regulates the release of hormones from the pituitary gland. Hormones: The "Chemical Messengers" Chemical messengers that carry information from one cell to another in the body. Hormones are carried throughout body by the blood, and are responsible for regulating many body functions. The body makes many hormones (e.g., thyroid, growth, sex and adrenal hormones) that work together to maintain normal bodily function. Hormones involved in the control of puberty include: GnRH: Gonadotropin releasing hormone, which comes from the brain in boys and in girls. Other androgens from the adrenal glands (located near the kidneys) produce pubic and axillary hair at the time of puberty. Estrogen: A female sex hormone, which is responsible for breast development in girls. It is made mainly by the ovaries, but is also present in boys in smaller amounts. Sex Hormones: Responsible for the development of pubertal signs as well as changes in behavior and the ability to have children. Precocious Puberty Precocious puberty means having signs of puberty (e.g., pubic hair or breast development) at an earlier age than usual. Normal Puberty There is a wide range of ages at which individuals normally start puberty.
    [Show full text]
  • Precocious Puberty Andrew Muir Pediatrics in Review 2006;27;373 DOI: 10.1542/Pir.27-10-373
    Precocious Puberty Andrew Muir Pediatrics in Review 2006;27;373 DOI: 10.1542/pir.27-10-373 The online version of this article, along with updated information and services, is located on the World Wide Web at: http://pedsinreview.aappublications.org/content/27/10/373 Pediatrics in Review is the official journal of the American Academy of Pediatrics. A monthly publication, it has been published continuously since 1979. Pediatrics in Review is owned, published, and trademarked by the American Academy of Pediatrics, 141 Northwest Point Boulevard, Elk Grove Village, Illinois, 60007. Copyright © 2006 by the American Academy of Pediatrics. All rights reserved. Print ISSN: 0191-9601. Downloaded from http://pedsinreview.aappublications.org/ at UNIV OF CHICAGO on May 23, 2013 Article endocrine Precocious Puberty Andrew Muir, MD* Objectives After completing this article, readers should be able to: 1. Know the normal ages of pubertal onset in boys and girls. Author Disclosure 2. Discuss the clinical signs of puberty, their usual sequence of appearance, and their Dr Muir did not typical rate of progression. disclose any financial 3. Use the physiology of puberty to diagnose the cause of abnormal puberty. relationships relevant 4. Describe the factors involved in the appropriate management of precocious puberty. to this article. 5. Determine whether to follow or refer children who have signs of early puberty. Introduction Although precocious puberty has standard clinical definitions and diagnostic tests are improving, the management of children who have signs of early puberty has become more complex in some ways during the last decade than ever before. This review illustrates how an understanding of the anatomy and physiology of puberty forms the foundation for managing children who experience puberty early.
    [Show full text]
  • Downloaded from Bioscientifica.Com at 09/25/2021 06:32:18PM Via Free Access
    1 184 A B Hansen and others Sex steroids in adolescencel 184:1 R17–R28 Review DIAGNOSIS OF ENDOCRINE DISEASE Sex steroid action in adolescence: too much, too little; too early, too late A B Hansen 1, D Wøjdemann1, C H Renault1, A T Pedersen 2, K M Main1, L L Raket3,4, R B Jensen1 and A Juul 1 Correspondence 1Department of Growth and Reproduction, 2Department of Gynecology and Fertility Clinic, Rigshospitalet, University should be addressed of Copenhagen, Copenhagen, Denmark, 3H. Lundbeck A/S, Valby, Hovedstaden, Denmark, and 4Clinical Memory to A Juul Research Unit, Department of Clinical Sciences, Lund University, Lund, Sweden Email [email protected] Abstract This review aims to cover the subject of sex steroid action in adolescence. It will include situations with too little sex steroid action, as seen in for example, Turners syndrome and androgen insensitivity issues, too much sex steroid action as seen in adolescent PCOS, CAH and gynecomastia, too late sex steroid action as seen in constitutional delay of growth and puberty and too early sex steroid action as seen in precocious puberty. This review will cover the etiology, the signs and symptoms which the clinician should be attentive to, important differential diagnoses to know and be able to distinguish, long-term health and social consequences of these hormonal disorders and the course of action with regards to medical treatment in the pediatric endocrinological department and for the general practitioner. This review also covers situations with exogenous sex steroid application for therapeutic purposes in the adolescent and young adult. This includes gender-affirming therapy in the transgender child and hormone treatment of tall statured children.
    [Show full text]
  • Precocious Puberty Dominique Long, MD Johns Hopkins University School of Medicine, Baltimore, MD
    Briefin Precocious Puberty Dominique Long, MD Johns Hopkins University School of Medicine, Baltimore, MD. AUTHOR DISCLOSURE Dr Long has disclosed Precocious puberty (PP) has traditionally been defined as pubertal changes fi no nancial relationships relevant to this occurring before age 8 years in girls and 9 years in boys. A secular trend toward article. This commentary does not contain fi a discussion of an unapproved/investigative earlier puberty has now been con rmed by recent studies in both the United use of a commercial product/device. States and Europe. Factors associated with earlier puberty include obesity, endocrine-disrupting chemicals (EDC), and intrauterine growth restriction. In 1997, a study by Herman-Giddens et al found that breast development was present in 15% of African American girls and 5% of white girls at age 7 years, which led to new guidelines published by the Lawson Wilkins Pediatric Endocrine Society (LWPES) proposing that breast development or pubic hair before age 7 years in white girls and age 6 years in African-American girls should be evaluated. More recently, Biro et al reported the onset of breast development at 8.8, 9.3, 9.7, and 9.7 years for African American, Hispanic, white non-Hispanic, and Asian study participants, respectively. The timing of menarche has not been shown to be advancing as quickly as other pubertal changes, with the average age between 12 and 12.5 years, similar to that reported in the 1970s. In boys, the Pediatric Research in Office Settings Network study recently found the mean age for onset of testicular enlargement, usually the first sign of gonadarche, is 10.14, 9.14, and 10.04 years in non-Hispanic white, African American, and Hispanic boys, respectively.
    [Show full text]
  • Premature Thelarche: a Guide for Families
    Pediatric Endocrinology Fact Sheet Premature Thelarche: A Guide for Families What is premature thelarche? to slightly increased. Some doctors will also order a bone age x-ray, but it is rare for the bone age to be significantly advanced, as is seen in true Thelarche is a medical term referring to the appearance of breast de- precocious puberty. velopment in girls, which usually occurs after age 8 years and is ac- companied by other signs of puberty, including a growth spurt. Prema- For girls who start developing breasts between the ages of 6 and 8 ture thelarche describes girls who develop a small amount of breast years, premature thelarche may still be the correct diagnosis, but true tissue (typically 1” or less across), typically before the age of 3 years. precocious puberty is more likely. Careful monitoring to see if there are The breasts do not get larger and the girl does not have a growth spurt. changes in the amount of breast tissue over time, additional tests, and A girl who has started puberty will show an increase in the size of her treatment are more likely to be needed. breasts within 4 to 6 months, but a girl with premature thelarche can go a year or more with little or no change in the size of the breasts How is premature thelarche treated? (sometimes, they will get smaller). Usually, both breasts are enlarged, but, sometimes, premature thelarche only affects one side. Premature Because this condition does not progress and there are no compli- thelarche differs from true precocious puberty, in which the typical cations, no medications are necessary.
    [Show full text]
  • 117. Ovarian Lesions
    CHAPTER 117 Ovarian Lesions Emily Stamell Adekunle O. Oguntayo Evan P. Nadler Introduction may explain why it is believed that pregnancy confers some protection Ovarian lesions in paediatric patients require special considerations against ovarian cancer, especially in women with high parity. The that may not be applicable in adult patients with comparable diseases. relevance of this theory in young children is unclear because they either Importantly, these lesions do not follow the same histologic distribution have not begun to ovulate or have ovulated very few times. Sex cord- as those seen in adults. They range from benign cysts that can regress stromal tumours arise from mesenchymal stem cells below the surface spontaneously to bilateral malignancies that require aggressive treatment. epithelium of the urogenital ridge. These cells have not committed to Gynecological malignancies account for about 1–2% of all paediatric a cell lineage; therefore, they can differentiate into different cell lines.5 cancers, and roughly 60–70% of gynecological malignancies are ovarian A number of syndromes are associated with ovarian tumours. in origin.1,2 The diagnosis of ovarian malignancies can often be challeng- Examples include, but are certainly not limited to, Peutz-Jeghers ing. Early detection is vital not only for fertility preservation, but also for syndrome and granulosa cell tumours, Ollier’s disease and juvenile cure or disease-free remission. Early detection may be even more diffi- granulosa cell tumours, Sertoli-Leydig cell tumours, and
    [Show full text]
  • Central Precocious Puberty in a Patient with X-Linked Adrenal Hypoplasia Congenita and Xp21 Contiguous Gene Deletion Syndrome
    Case report http://dx.doi.org/10.6065/apem.2013.18.2.90 Ann Pediatr Endocrinol Metab 2013;18:90-94 Central precocious puberty in a patient with X-linked adrenal hypoplasia congenita and Xp21 contiguous gene deletion syndrome Ji Won Koh, MD1, X-linked adrenal hypoplasia congenita is caused by the mutation of DAX-1 gene So Young Kang, MD1, (dosage-sensitive sex reversal, adrenal hypoplasia critical region, on chromosome X, Gu Hwan Kim, PhD2, gene 1), and can occur as part of a contiguous gene deletion syndrome in association Han Wook Yoo, MD, PhD2, with glycerol kinase (GK) deficiency, Duchenne muscular dystrophy and X-linked Jeesuk Yu, MD, PhD1 interleukin-1 receptor accessory protein-like 1 (IL1RAPL1) gene deficiency. It is usually associated with hypogonadotropic hypogonadism, although in rare cases, it has been 1 reported to occur in normal puberty or even central precocious puberty. This study Department of Pediatrics, Dankook addresses a case in which central precocious puberty developed in a boy with X-linked University College of Medicine, 2 adrenal hypoplasia congenita who had complete deletion of the genes DAX-1, GK Cheonan, Medical Genetics Center, Asan Medical Center, Seoul, Korea and IL1RAPL1 (Xp21 contiguous gene deletion syndrome). Initially he was admitted for the management of adrenal crisis at the age of 2 months, and managed with hydrocortisone and florinef. At 45 months of age, his each testicular volumes of 4 mL and a penile length of 5 cm were noted, with pubic hair of Tanner stage 2. His bone age was advanced and a gonadotropin-releasing hormone (GnRH) stimulation test showed a luteinizing hormone peak of 8.26 IU/L, confirming central precocious puberty.
    [Show full text]
  • Central Precocious Puberty: Revisiting the Diagnosis and Therapeutic
    review Central precocious puberty: revisiting the diagnosis and therapeutic management Vinícius Nahime Brito1, Angela Maria Spinola-Castro1, Cristiane Kochi2, Cristiane Kopacek2, Paulo César Alves da Silva1, Gil Guerra-Júnior2 ABSTRACT 1 Departamento de Endocrinologia Clinical and laboratory diagnosis and treatment of central precocious puberty (CPP) remain chal- Pediátrica, Sociedade Brasileira lenging due to lack of standardization. The aim of this revision was to address the diagnostic and de Endocrinologia e Metabologia (SBEM), Rio de Janeiro, RJ, Brasil therapeutic features of CPP in Brazil based on relevant international literature and availability of the 2 Departamento de Endocrinologia, existing therapies in the country. The diagnosis of CPP is based mainly on clinical and biochemical Sociedade Brasileira de Pediatria parameters, and a period of follow-up is desirable to define the “progressive” form of sexual precoc- (SBP), Rio de Janeiro, RJ, Brasil ity. This occurs due to the broad spectrum of pubertal development, including isolated premature thelarche, constitutional growth and puberty acceleration, progressive and nonprogressive CPP, and Correspondence to: early puberty. Measurement of basal and stimulated LH levels remains challenging, considering that Gil Guerra-Júnior the levels are not always in the pubertal range at baseline, short-acting GnRH is not readily available Departamento de Pediatria, in Brazil, and the cutoff values differ according to the laboratory assay. When CPP is suspected but Faculdade de Ciências Médicas, basal LH values are at prepubertal range, a stimulation test with short-acting or long-acting monthly Universidade Estadual de Campinas GnRH is a diagnostic option. In Brazil, the treatment of choice for progressive CPP and early puberty Rua Tessália Vieira de Camargo, 126 is a long-acting GnRH analog (GnRHa) administered once a month or every 3 months.
    [Show full text]
  • Precocious Puberty Secondary to Massive Ovarian Oedema in a 6
    European Journal of Endocrinology (2004) 150 119–123 ISSN 0804-4643 CASE REPORT Precocious puberty secondary to massive ovarian oedema in a 6-month-old girl Anuja Natarajan, Jeremy K H Wales, 1Sean S Marven and Neil P Wright Departments of Paediatric Endocrinology and 1Surgery, Sheffield Children’s Hospital, Western Bank, Sheffield S10 2TH, UK (Correspondence should be addressed to N P Wright; Email: [email protected]) Abstract A 6-month-old girl was referred with breast and pubic hair development. Investigations excluded an adrenal or central cause for her precocity. Ovarian ultrasound scans showed bilaterally enlarged ovaries with both solid and cystic changes. A follow-up examination suggested progression of the precocity and in view of the young age of the child, and concerns regarding underlying malignancy, she underwent laparotomy. Histology showed no evidence of neoplasia but there was stromal oedema consistent with a diagnosis of massive ovarian oedema. This entity is poorly recognised in the paedia- tric literature as a cause of sexual precocity, and has never previously been described in such a young patient. This is an unusual cause of precocity in a young child and its recognition and management are reviewed. European Journal of Endocrinology 150 119–123 Introduction (DHEAS) 0.8 mmol/l (normal ranges for a pre-pubertal child are testosterone ,0.5 nmol/l and DHEAS A 6-month-old girl was referred with a 3-month ,0.5 mmol/l). Bone age estimation by the Tanner– history of pubic hair and breast development. She was Whitehouse 2 method (2) was advanced by 6 months.
    [Show full text]